Celldex Therapeutics Stock Sees Short Interest Move 10.2% Lower
March 28, 2016 at 15:01 PM EDT
The most recent short interest data has been released by the NASDAQ for the 03/15/2016 settlement date, which shows a 2,611,494 share decrease in total short interest for Celldex Therapeutics, Inc. (CLDX), to 22,991,585, a decrease of 10.20% since 02/29/2016..
